Bajaj HealthCare Limited (BAJAJHCARE.BO)
INR 593.0
(6.08%)
INR 593.0
(6.08%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.44 Billion INR | -31.01% |
| 2022 | 2.08 Billion INR | 31.1% |
| 2021 | 1.59 Billion INR | 64.0% |
| 2020 | 971.1 Million INR | 147.26% |
| 2019 | 392.75 Million INR | 30.71% |
| 2018 | 300.47 Million INR | -10.73% |
| 2017 | 336.59 Million INR | 100.83% |
| 2016 | 167.59 Million INR | -14.66% |
| 2015 | 196.39 Million INR | 8.62% |
| 2014 | 180.81 Million INR | -22.08% |
| 2013 | 232.03 Million INR | 42.78% |
| 2012 | 162.51 Million INR | -8.86% |
| 2011 | 178.3 Million INR | -9.76% |
| 2010 | 197.59 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 1.44 Billion INR | -31.01% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 1.44 Billion INR | 0.0% |
| 2023 Q2 | 2.02 Billion INR | 0.0% |
| 2022 Q2 | 1.83 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 2.08 Billion INR | 31.1% |
| 2022 Q4 | 2.08 Billion INR | 0.0% |
| 2021 Q2 | 1.57 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 1.59 Billion INR | 64.0% |
| 2021 Q4 | 1.59 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 971.1 Million INR | 147.26% |
| 2020 Q4 | 971.1 Million INR | 0.0% |
| 2020 Q2 | 724.89 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q2 | 305.33 Million INR | 0.0% |
| 2019 FY | 392.75 Million INR | 30.71% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 392.75 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q1 | 392.83 Million INR | 16.71% |
| 2018 Q4 | 300.47 Million INR | 0.0% |
| 2018 FY | 300.47 Million INR | -10.73% |
| 2018 Q3 | 300.47 Million INR | -23.51% |
| 2018 Q2 | 392.83 Million INR | 0.0% |
| 2017 Q4 | 336.59 Million INR | 0.0% |
| 2017 FY | 336.59 Million INR | 100.83% |
| 2017 Q3 | 336.59 Million INR | 35.73% |
| 2017 Q2 | 247.99 Million INR | 0.0% |
| 2017 Q1 | 247.99 Million INR | 47.97% |
| 2016 Q2 | 195.89 Million INR | 0.0% |
| 2016 FY | 167.59 Million INR | -14.66% |
| 2016 Q4 | 167.59 Million INR | 0.0% |
| 2016 Q3 | 167.59 Million INR | -14.44% |
| 2016 Q1 | 195.89 Million INR | -0.26% |
| 2015 Q3 | 213.33 Million INR | -4.47% |
| 2015 Q1 | 223.32 Million INR | 0.0% |
| 2015 Q2 | 223.32 Million INR | 0.0% |
| 2015 FY | 196.39 Million INR | 8.62% |
| 2015 Q4 | 196.39 Million INR | -7.94% |
| 2014 FY | 180.81 Million INR | -22.08% |
| 2013 FY | 232.03 Million INR | 42.78% |
| 2012 FY | 162.51 Million INR | -8.86% |
| 2011 FY | 178.3 Million INR | -9.76% |
| 2010 FY | 197.59 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Ajanta Pharma Limited | 8.28 Billion INR | 82.612% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -398.321% |
| Sigachi Industries Limited | 707.2 Million INR | -103.672% |
| Bal Pharma Limited | 878.11 Million INR | -64.031% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -1277.341% |
| Medico Remedies Limited | 163.37 Million INR | -781.658% |
| Lasa Supergenerics Limited | 190.43 Million INR | -656.368% |
| Venus Remedies Limited | 1.21 Billion INR | -18.365% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Alpa Laboratories Limited | 136.65 Million INR | -954.043% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 79.689% |
| Shilpa Medicare Limited | 3.44 Billion INR | 58.241% |
| Aarti Drugs Limited | 4.85 Billion INR | 70.356% |
| Lupin Limited | 49.53 Billion INR | 97.092% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 98.531% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 95.815% |
| Windlas Biotech Limited | 621.89 Million INR | -131.614% |
| Suven Life Sciences Limited | 7.08 Million INR | -20230.021% |
| Eris Lifesciences Limited | 1.89 Billion INR | 23.802% |
| Valiant Laboratories Limited | 100.15 Million INR | -1338.167% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 71.336% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 59.956% |
| Ipca Laboratories Limited | 24.71 Billion INR | 94.172% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -21.605% |
| Achyut Healthcare Limited | 568 Thousand INR | -253488.38% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 98.54% |
| RPG Life Sciences Limited | 1.01 Billion INR | -42.612% |
| Mankind Pharma Limited | 15.53 Billion INR | 90.728% |
| Laurus Labs Limited | 18.45 Billion INR | 92.195% |
| Piramal Pharma Limited | 21.75 Billion INR | 93.38% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -583.245% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 93.68% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 91.236% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 94.268% |
| Unichem Laboratories Limited | 7.04 Billion INR | 79.56% |
| Sequent Scientific Limited | 3.46 Billion INR | 58.398% |
| Novartis India Limited | 448.6 Million INR | -221.084% |
| Wanbury Limited | 360.23 Million INR | -299.848% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 37.699% |
| Wockhardt Limited | 6.4 Billion INR | 77.494% |
| Themis Medicare Limited | 705.74 Million INR | -104.094% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -860.447% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 88.831% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 78.392% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 97.734% |
| Divi's Laboratories Limited | 31.84 Billion INR | 95.476% |
| NATCO Pharma Limited | 7 Billion INR | 79.438% |
| Gufic Biosciences Limited | 2 Billion INR | 28.154% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 66.096% |
| Ind-Swift Limited | 640.91 Million INR | -124.738% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -32.012% |
| FDC Limited | 3.88 Billion INR | 62.962% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -1370.318% |
| Granules India Limited | 13 Billion INR | 88.925% |
| Medicamen Biotech Limited | 593.75 Million INR | -142.59% |
| Alkem Laboratories Limited | 26.61 Billion INR | 94.587% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 36.793% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -5549.221% |
| Brooks Laboratories Limited | 96.1 Million INR | -1398.712% |
| Megasoft Limited | - INR | -Infinity% |
| ZIM Laboratories Limited | 812.62 Million INR | -77.25% |
| Strides Pharma Science Limited | 11.26 Billion INR | 87.211% |
| Neuland Laboratories Limited | 3.5 Billion INR | 58.896% |
| Morepen Laboratories Limited | 2.48 Billion INR | 42.059% |
| Hikal Limited | 3.03 Billion INR | 52.575% |
| Indoco Remedies Limited | 3.53 Billion INR | 59.203% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 77.594% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -3511.79% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -16.498% |
| Hester Biosciences Limited | 755.81 Million INR | -90.575% |